Loading...

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer

Since 2004, the clinical impact of monoclonal antibodies (mAbs) targeting the epidermal growth factor receptor (EGFR) on patients with metastatic colorectal cancer (MCRC) has been clearly established. The combination of these biological agents with conventional chemotherapy has led to a significant...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Fiore, F, Sesboüé, R, Michel, P, Sabourin, J C, Frebourg, T
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2010
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3008616/
https://ncbi.nlm.nih.gov/pubmed/21139621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6606008
Tags: Add Tag
No Tags, Be the first to tag this record!